Speaking on: Concurrent and isoform specific loss of RNF128/GRAIL and UBCH5 promotes Barrett’s progression.

Med Sci I, Room 3114 (C-wing)
Contact Kurt Nelson
Dipankar Ray, PhD
Speaking on: Concurrent and isoform specific loss of RNF128/GRAIL and UBCH5 promotes Barrett’s progression.